20 results
DEF 14A
COYA
Coya Therapeutics Inc
19 May 23
Definitive proxy
4:31pm
Leadership Structure and Role in Risk Oversight
Evaluations of the Board of Directors
Stockholder Communications
Code of Business Conduct and Ethics
Anti … and Corporate Governance Committee may take into account many factors, including: personal and professional integrity, ethics and values; experience
10-Q
EX-10.1
9ylchslr13m hngct
10 May 23
Quarterly report
7:14am
10-K
8ah7byux459f0pzam
29 Mar 23
Annual report
4:08pm
10-K
EX-3.2
d9uqjdqqpz x0
29 Mar 23
Annual report
4:08pm
424B4
478c1k6j
30 Dec 22
Prospectus supplement with pricing info
4:17pm
S-1/A
o2nm28veye94n5spt
5 Dec 22
IPO registration (amended)
8:16am
S-1/A
EX-10.7
chfwdjr92
5 Dec 22
IPO registration (amended)
8:16am
S-1
EX-10.7
lvd3h6sl02opc61lm
18 Nov 22
IPO registration
5:06pm
S-1
d5pfoq v9
18 Nov 22
IPO registration
5:06pm
S-1
EX-3.4
qus4t
18 Nov 22
IPO registration
5:06pm
DRS/A
EX-3
r2pjnsi8przz1zr
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
7ni b1utdmzcmhcegbou
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
ukeug3eyir95 nq7ju8
7 Oct 22
Draft registration statement (amended)
12:00am
DRS
epwb4
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next